Active Studies at DVTU

If you are interested in participating in a Duke Vaccine and Trials Unit study, please contact us to receive notices about current and future research studies.

Email: dvtustudies@duke.edu | Telephone: 919-971-5649


Active Clinical Trials

 

Dr. Walter is leading a study designed to obtain blood from Duke employees who are recovering from SARS-CoV-2 infection for the purposes of neutralizing antibody assay validation. No NCT number.   


Dr. Smith is leading a study to assess the safety, tolerability, and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy infants. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06524414.


Dr. Walter is leading A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen (Bird Flu) mRNA-LNP Vaccine in Healthy Adults.  Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07019883.


Dr. Walter is leading A Study to Evaluate the Safety and Immunogenicity of Two Doses of a novel adjuvanted pancoronavirus vaccine in Healthy Adults.  Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06950177.